ID

18319

Descrição

Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00181220

Link

https://clinicaltrials.gov/show/NCT00181220

Palavras-chave

Versões (1)
  1. 31/10/2016 31/10/2016 -
Transferido a

31 de outubro de 2016

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Nasopharyngeal Carcinoma NCT00181220

Inglês

Eligibility Nasopharyngeal Carcinoma NCT00181220

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
all subjects must fulfill the following criteria to be eligible for study admission:
Descrição

Clinical Trial Eligibility Criteria Fulfill

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C1550543
subjects are of age 18 years and above
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
biopsy proven nasopharyngeal carcinoma – who type 3
Descrição

Nasopharyngeal carcinoma | Biopsy | WHO performance status scale

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2931822
UMLS CUI [2]
C0005558
UMLS CUI [3]
C1298650
must have tumor which is accessible to biopsy
Descrição

Neoplasm Amenable Biopsy

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C3900053
UMLS CUI [1,3]
C0005558
for patients with disease localized to the pns, the lesion must be visualized by endoscopy
Descrição

Lesion Localized Nasal sinus | Endoscopy

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0221198
UMLS CUI [1,2]
C0392752
UMLS CUI [1,3]
C0030471
UMLS CUI [2]
C0014245
subjects with metastatic disease with disease accessible to biopsy in the pns if they are deemed by their treating physicians not to require treatment for at least two weeks.
Descrição

Neoplasm Metastasis | Disease Amenable Paranasal biopsy | treatment need

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0027627
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C3900053
UMLS CUI [2,3]
C0857438
UMLS CUI [3]
C0815189
an ecog performance status of 0–2
Descrição

ECOG performance status

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
for sexually active women of child-bearing potential, negative pregnancy test within 14 days of enrolling on trial
Descrição

Childbearing Potential Sex Behavior Pregnancy test negative

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0036864
UMLS CUI [1,3]
C0427780
must be able to give informed consent
Descrição

Informed Consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
for patients with localized npc, pns lesions that cannot be visualized by endoscopy
Descrição

Nasopharyngeal carcinoma Localized | Nasal sinus Lesion | Endoscopy

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C2931822
UMLS CUI [1,2]
C0392752
UMLS CUI [2,1]
C0030471
UMLS CUI [2,2]
C0221198
UMLS CUI [3]
C0014245
patients with disease inaccessible to biopsy
Descrição

Disease Amenable Biopsy

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C3900053
UMLS CUI [1,3]
C0005558
history of anaphylaxis after exposure to valproic acid
Descrição

anaphylaxis | Valproic Acid Exposure to

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0002792
UMLS CUI [2,1]
C0042291
UMLS CUI [2,2]
C0332157
hepatic dysfunction as defined by total bilirubin 1.0x upper limit of normal. ast (sgot) and alt (sgpt)  3x upper limit of normal
Descrição

Liver Dysfunction | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0086565
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201899
UMLS CUI [4]
C0201836
hemoglobin  8g/dl, absolute neutrophil count 1500 cells/mm, and platelet count 100,000 /mm
Descrição

Hemoglobin | Absolute neutrophil count | Platelet Count measurement

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0019046
UMLS CUI [2]
C0948762
UMLS CUI [3]
C0032181
creatinine 3x upper limit of normal
Descrição

Creatinine measurement, serum

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0201976
pt/ptt blood test result not within normal range
Descrição

Prothrombin time abnormal | Abnormal partial thromboplastin time (PTT)

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0580412
UMLS CUI [2]
C4062448
patients who require treatment with an anticonvulsant besides valproic acid during the course of valproate prescribed by the protocol
Descrição

Anticonvulsant Patient need for | Valproic Acid | Valproate

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0003286
UMLS CUI [1,2]
C0686904
UMLS CUI [2]
C0042291
UMLS CUI [3]
C0080356
ecog performance status 3-4
Descrição

ECOG performance status

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
patients who are pregnant or breast feeding (sexually active women of childbearing potential must use contraception during course of therapy and within 4 weeks of completion of trial)
Descrição

Pregnancy | Breast Feeding | Childbearing Potential Sex Behavior Contraceptive methods

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0036864
UMLS CUI [3,3]
C0700589
participation in another clinical trial involving therapeutic intervention within 4 weeks of enrollment.
Descrição

Study Subject Participation Status | Operative Surgical Procedures

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0543467
Voltar ao início da página

Similar models

Eligibility Nasopharyngeal Carcinoma NCT00181220

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Clinical Trial Eligibility Criteria Fulfill
Item
all subjects must fulfill the following criteria to be eligible for study admission:
boolean
C1516637 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Age
Item
subjects are of age 18 years and above
boolean
C0001779 (UMLS CUI [1])
Nasopharyngeal carcinoma | Biopsy | WHO performance status scale
Item
biopsy proven nasopharyngeal carcinoma – who type 3
boolean
C2931822 (UMLS CUI [1])
C0005558 (UMLS CUI [2])
C1298650 (UMLS CUI [3])
Neoplasm Amenable Biopsy
Item
must have tumor which is accessible to biopsy
boolean
C0027651 (UMLS CUI [1,1])
C3900053 (UMLS CUI [1,2])
C0005558 (UMLS CUI [1,3])
Lesion Localized Nasal sinus | Endoscopy
Item
for patients with disease localized to the pns, the lesion must be visualized by endoscopy
boolean
C0221198 (UMLS CUI [1,1])
C0392752 (UMLS CUI [1,2])
C0030471 (UMLS CUI [1,3])
C0014245 (UMLS CUI [2])
Neoplasm Metastasis | Disease Amenable Paranasal biopsy | treatment need
Item
subjects with metastatic disease with disease accessible to biopsy in the pns if they are deemed by their treating physicians not to require treatment for at least two weeks.
boolean
C0027627 (UMLS CUI [1])
C0012634 (UMLS CUI [2,1])
C3900053 (UMLS CUI [2,2])
C0857438 (UMLS CUI [2,3])
C0815189 (UMLS CUI [3])
ECOG performance status
Item
an ecog performance status of 0–2
boolean
C1520224 (UMLS CUI [1])
Childbearing Potential Sex Behavior Pregnancy test negative
Item
for sexually active women of child-bearing potential, negative pregnancy test within 14 days of enrolling on trial
boolean
C3831118 (UMLS CUI [1,1])
C0036864 (UMLS CUI [1,2])
C0427780 (UMLS CUI [1,3])
Informed Consent
Item
must be able to give informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Nasopharyngeal carcinoma Localized | Nasal sinus Lesion | Endoscopy
Item
for patients with localized npc, pns lesions that cannot be visualized by endoscopy
boolean
C2931822 (UMLS CUI [1,1])
C0392752 (UMLS CUI [1,2])
C0030471 (UMLS CUI [2,1])
C0221198 (UMLS CUI [2,2])
C0014245 (UMLS CUI [3])
Disease Amenable Biopsy
Item
patients with disease inaccessible to biopsy
boolean
C0012634 (UMLS CUI [1,1])
C3900053 (UMLS CUI [1,2])
C0005558 (UMLS CUI [1,3])
anaphylaxis | Valproic Acid Exposure to
Item
history of anaphylaxis after exposure to valproic acid
boolean
C0002792 (UMLS CUI [1])
C0042291 (UMLS CUI [2,1])
C0332157 (UMLS CUI [2,2])
Liver Dysfunction | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
hepatic dysfunction as defined by total bilirubin 1.0x upper limit of normal. ast (sgot) and alt (sgpt)  3x upper limit of normal
boolean
C0086565 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
Hemoglobin | Absolute neutrophil count | Platelet Count measurement
Item
hemoglobin  8g/dl, absolute neutrophil count 1500 cells/mm, and platelet count 100,000 /mm
boolean
C0019046 (UMLS CUI [1])
C0948762 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
Creatinine measurement, serum
Item
creatinine 3x upper limit of normal
boolean
C0201976 (UMLS CUI [1])
Prothrombin time abnormal | Abnormal partial thromboplastin time (PTT)
Item
pt/ptt blood test result not within normal range
boolean
C0580412 (UMLS CUI [1])
C4062448 (UMLS CUI [2])
Anticonvulsant Patient need for | Valproic Acid | Valproate
Item
patients who require treatment with an anticonvulsant besides valproic acid during the course of valproate prescribed by the protocol
boolean
C0003286 (UMLS CUI [1,1])
C0686904 (UMLS CUI [1,2])
C0042291 (UMLS CUI [2])
C0080356 (UMLS CUI [3])
ECOG performance status
Item
ecog performance status 3-4
boolean
C1520224 (UMLS CUI [1])
Pregnancy | Breast Feeding | Childbearing Potential Sex Behavior Contraceptive methods
Item
patients who are pregnant or breast feeding (sexually active women of childbearing potential must use contraception during course of therapy and within 4 weeks of completion of trial)
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0036864 (UMLS CUI [3,2])
C0700589 (UMLS CUI [3,3])
Study Subject Participation Status | Operative Surgical Procedures
Item
participation in another clinical trial involving therapeutic intervention within 4 weeks of enrollment.
boolean
C2348568 (UMLS CUI [1])
C0543467 (UMLS CUI [2])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial